Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB06616_nanopub.RASNpli7UPl1RAr9MteXvPefNMfpA9W81RriZi7k3uWRA#assertion>. }
Showing items 1 to 20 of
20
with 100 items per page.
- drugbank:DB06616 type drugbank_vocabulary:Drug assertion.
- drugbank:DB06616 label "Bosutinib [drugbank:DB06616]" assertion.
- drugbank:DB06616 seeAlso DB06616 assertion.
- drugbank:DB06616 seeAlso bosutinib.html assertion.
- drugbank:DB06616 seeAlso bosulif-drug.htm assertion.
- drugbank:DB06616 identifier "drugbank:DB06616" assertion.
- drugbank:DB06616 description "Bosutinib is a Bcr-Abl kinase inhibitor for the treatment of Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML). Compared to other tyrosine kinase inhibitors, it has a more favourable hematologic toxicity profile. FDA approved on September 4, 2012." assertion.
- drugbank:DB06616 title "Bosutinib" assertion.
- drugbank:DB06616 bio2rdf_vocabulary:identifier "DB06616" assertion.
- drugbank:DB06616 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB06616 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB06616" assertion.
- drugbank:DB06616 bio2rdf_vocabulary:x-identifiers.org DB06616 assertion.
- drugbank:DB06616 drugbank_vocabulary:drugbank-id "DB06616" assertion.
- drugbank:DB06616 drugbank_vocabulary:x-cas cas:380843-75-4 assertion.
- drugbank:DB06616 drugbank_vocabulary:x-ahfs ahfs:10:00 assertion.
- drugbank:DB06616 drugbank_vocabulary:x-atc atc:L01XE14 assertion.
- drugbank:DB06616 drugbank_vocabulary:x-chebi chebi:39112 assertion.
- drugbank:DB06616 drugbank_vocabulary:x-kegg kegg:D03252 assertion.
- drugbank:DB06616 drugbank_vocabulary:x-wikipedia wikipedia:Bosutinib assertion.
- drugbank:DB06616 drugbank_vocabulary:x-ndc ndc:0069-0136-01 assertion.